HPV-FRAME will be a quality framework which will enable a set of standards that ensure models of HPV prevention contribute to an optimal decision-making process.
As background to the specific discussion of HPV models to occur in this session, this talk will ‘set the scene’ via discussion of the general principles of good modelling practice as articulated in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines for good modelling practice, which include general principles for model calibration, validation and uncertainty and sensitivity analysis.
HPV-FRAME will supplement general principles of good modelling practice as articulated by ISPOR, via the provision of specific guidance on issues of relevance in HPV modelling.